The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Shibata, Keisuke ^a   Sugawara, Takeshi ^a,b   Fujishita, Kayoko ^a   Shinozaki, Youichi ^a   Matsukawa, Takashi ^a   Suzuki, Tsutomu ^c   Koizumi, Schuichi ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b Kenyudo Clinic   (Japan)

^c HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSHI; FLUOROCITRIC ACID; HERBACEOUS AGENT; INTERLEUKIN 18; INTERLEUKIN 1BETA; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TJ 3023; UNCLASSIFIED DRUG; ANALGESIC AGENT; CITRIC ACID; PLANT EXTRACT;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DISEASE MODEL; DRUG SCREENING; ENZYME PHOSPHORYLATION; HERBAL MEDICINE; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; NERVE CELL CULTURE; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; TARGET CELL; TEMPORAL LOBE; ANIMAL; CELL CULTURE; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; NEURALGIA; PATHOLOGY; PHYTOTHERAPY; SPINAL CORD; TIME;

MUS;

ANALGESICS; ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; CELLS, CULTURED; CITRATES; DISEASE MODELS, ANIMAL; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SPINAL; MICE; MICE, INBRED ICR; MICROGLIA; MINOCYCLINE; NEURALGIA; PAIN MEASUREMENT; PHYTOTHERAPY; PLANT EXTRACTS; SPINAL CORD; TIME FACTORS;

EID: 80051843478     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023510     Document Type: Article

References (54)

1. Baron R, (2006) Mechanisms of disease: neuropathic pain-a clinical perspective. Nat Clin Pract Neurol 2: 95-106.
2. Scholz J, Woolf CJ, (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10: 1361-1368.
3. Tsuda M, Inoue K, Salter MW, (2005) Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 28: 101-107.
4. Woolf CJ, Mannion RJ, (1999) Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353: 1959-1964.
5. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, et al. (2003) Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60: 1524-1534.
6. De Leo JA, Tawfik VL, LaCroix-Fralish ML, (2006) The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain 122: 17-21.
7. McMahon SB, Cafferty WB, Marchand F, (2005) Immune and glial cell factors as pain mediators and modulators. Exp Neurol 192: 444-462.
8. Watkins LR, Maier SF, (2002) Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82: 981-1011.
9. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, et al. (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424: 778-783.
10. Marchand F, Perretti M, McMahon SB, (2005) Role of the immune system in chronic pain. Nat Rev Neurosci 6: 521-532.
11. Suter MR, Wen YR, Decosterd I, Ji RR, (2007) Do glial cells control pain? Neuron Glia Biol 3: 255-268.
12. Watkins LR, Milligan ED, Maier SF, (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24: 450-455.
13. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, et al. (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438: 1017-1021.
14. Raghavendra V, Tanga F, DeLeo JA, (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306: 624-630.
15. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, et al. (2005) Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115: 71-83.
16. Benarroch EE, (2010) Central neuron-glia interactions and neuropathic pain: overview of recent concepts and clinical implications. Neurology 75: 273-278.
17. Milligan ED, Watkins LR, (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10: 23-36.
18. Haydon PG, (2001) GLIA: listening and talking to the synapse. Nat Rev Neurosci 2: 185-193.
19. Koizumi S, Fujishita K, Tsuda M, Shigemoto-Mogami Y, Inoue K, (2003) Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proc Natl Acad Sci U S A 100: 11023-11028.
20. Perea G, Navarrete M, Araque A, (2009) Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32: 421-431.
21. Araque A, (2008) Astrocytes process synaptic information. Neuron Glia Biol 4: 3-10.
22. Nakagawa T, Wakamatsu K, Zhang N, Maeda S, Minami M, et al. (2007) Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanisms in the phase of the induction and maintenance. Neuroscience 147: 445-455.
23. Wei F, Guo W, Zou S, Ren K, Dubner R, (2008) Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci 28: 10482-10495.
24. Okada-Ogawa A, Suzuki I, Sessle BJ, Chiang CY, Salter MW, et al. (2009) Astroglia in medullary dorsal horn (trigeminal spinal subnucleus caudalis) are involved in trigeminal neuropathic pain mechanisms. J Neurosci 29: 11161-11171.
25. Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K, (2008) Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci 28: 12775-12787.
26. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, et al. (2008) Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14: 331-336.
27. Goldman N, Chen M, Fujita T, Xu Q, Peng W, et al. (2010) Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci 13: 883-888.
28. Brunelli B, Gorson KC, (2004) The use of complementary and alternative medicines by patients with peripheral neuropathy. J Neurol Sci 218: 59-66.
29. Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ, (2006) Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol 24: 5457-5464.
30. Suzuki Y, Goto K, Ishige A, Komatsu Y, Kamei J, (1999) Antinociceptive effect of Gosha-jinki-gan, a Kampo medicine, in streptozotocin-induced diabetic mice. Jpn J Pharmacol 79: 169-175.
31. Yamamoto T, Murai T, Ueda M, Katsuura M, Oishi M, et al. (2009) [Clinical features of paclitaxel-induced peripheral neuropathy and role of Gosya-jinki-gan]. Gan To Kagaku Ryoho 36: 89-92.
32. Murayama M, Mori T, Bando H, Amiya T, (1991) Studies on the constituents of Aconitum species. IX. The pharmacological properties of pyro-type aconitine alkaloids, components of processed aconite powder 'kako-bushi-matsu': analgesic, antiinflammatory and acute toxic activities. J Ethnopharmacol 35: 159-164.
33. Tawata M, Kurihara A, Nitta K, Iwase E, Gan N, et al. (1994) The effects of goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy. Diabetes Res Clin Pract 26: 121-128.
34. Ji RR, Gereau RWt, Malcangio M, Strichartz GR, (2009) MAP kinase and pain. Brain Res Rev 60: 135-148.
35. Van Dam AM, Bauer J, Tilders FJ, Berkenbosch F, (1995) Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 65: 815-826.
36. Clark AK, D'Aquisto F, Gentry C, Marchand F, McMahon SB, et al. (2006) Rapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammation. J Neurochem 99: 868-880.
37. Chen RH, Sarnecki C, Blenis J, (1992) Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol 12: 915-927.
38. Inoue K, Tsuda M, (2009) Microglia and neuropathic pain. Glia 57: 1469-1479.
39. Ji RR, Kawasaki Y, Zhuang ZY, Wen YR, Decosterd I, (2006) Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol 2: 259-269.
40. Svensson CI, Brodin E, (2010) Spinal astrocytes in pain processing: non-neuronal cells as therapeutic targets. Mol Interv 10: 25-38.
41. Middeldorp J, Hol EM, (2011) GFAP in health and disease. Prog Neurobiol 93: 421-443.
42. Abbadie C, Bhangoo S, De Koninck Y, Malcangio M, Melik-Parsadaniantz S, et al. (2009) Chemokines and pain mechanisms. Brain Res Rev 60: 125-134.
43. Gao YJ, Ji RR, (2010) Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 126: 56-68.
44. Gao YJ, Ji RR, (2010) Targeting astrocyte signaling for chronic pain. Neurotherapeutics 7: 482-493.
45. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, et al. (2007) Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 27: 6006-6018.
46. Yang S, Liu ZW, Wen L, Qiao HF, Zhou WX, et al. (2005) Interleukin-1beta enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission. Brain Res 1034: 172-179.
47. Zhuang ZY, Gerner P, Woolf CJ, Ji RR, (2005) ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114: 149-159.
48. Wegert S, Ossipov MH, Nichols ML, Bian D, Vanderah TW, et al. (1997) Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Pain 71: 57-64.
49. Goncharov NV, Jenkins RO, Radilov AS, (2006) Toxicology of fluoroacetate: a review, with possible directions for therapy research. J Appl Toxicol 26: 148-161.
50. Proudfoot AT, Bradberry SM, Vale JA, (2006) Sodium fluoroacetate poisoning. Toxicol Rev 25: 213-219.
51. Aftanas LI, Golosheikin SA, (2002) Guiding principles for the care and use of animals in the field of physiological sciences. Nippon Seirigaku Zasshi 64: 143-146.
52. Seltzer Z, Dubner R, Shir Y, (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43: 205-218.
53. Malmberg AB, Brandon EP, Idzerda RL, Liu H, McKnight GS, et al. (1997) Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase. J Neurosci 17: 7462-7470.
54. Takasaki I, Andoh T, Shiraki K, Kuraishi Y, (2000) Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice. Pain 86: 95-101.